tiprankstipranks
Caribou Biosciences (CRBU)
NASDAQ:CRBU
US Market

Caribou Biosciences (CRBU) Financial Statements

603 Followers

Caribou Biosciences Financial Overview

Caribou Biosciences's market cap is currently ―. The company's EPS TTM is $-1.451; its P/E ratio is -1.88; Caribou Biosciences is scheduled to report earnings on August 6, 2024, and the estimated EPS forecast is $-0.46. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 2.43M$ 3.56M$ 23.66M$ 3.75M$ 3.50M
Gross Profit$ 2.43M$ 3.56M$ 23.66M$ 3.75M$ 3.50M
EBIT$ -46.00M$ -37.44M$ -10.00M$ -29.52M$ -28.30M
EBITDA$ -45.29M$ -36.70M-$ -31.01M$ -29.20M
Net Income Common Stockholders$ -41.23M$ -34.51M$ -10.00M$ -29.52M$ -28.04M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 293.99M$ 328.83M$ 338.49M$ 259.23M$ 228.54M
Total Assets$ 406.82M$ 432.21M$ 457.52M$ 349.65M$ 347.46M
Total Debt$ 27.16M$ 27.11M$ 27.45M$ 27.23M$ 27.42M
Net Debt$ -266.83M$ -301.72M$ -311.03M$ -232.00M$ -201.12M
Total Liabilities$ 63.54M$ 63.81M$ 59.25M$ 80.19M$ 69.19M
Stockholders Equity$ 343.29M$ 368.40M$ 398.27M$ 269.44M$ 278.27M
Cash Flow-
Free Cash Flow$ -38.65M$ -23.68M-$ -17.70M$ -29.98M
Operating Cash Flow$ -37.20M$ -21.40M$ -28.80M$ -15.14M$ -27.95M
Investing Cash Flow$ 22.96M$ -31.47M$ -68.48M$ 11.06M$ 20.70M
Financing Cash Flow$ 12.48M$ -43.00K$ 135.13M$ 17.57M$ 1.64M
Currency in USD

Caribou Biosciences Earnings and Revenue History

Caribou Biosciences Debt to Assets

Caribou Biosciences Cash Flow

Caribou Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis